| COHERUS ONCOLOGY DL-,0001 |
| USA |
| Gesundheit |
| US19249H1032 / A12ETZ |
| 8C5 (Frankfurt) / CHRS (NASDAQ) |
| FRA:8C5, ETR:8C5, 8C5:GR, NASDAQ:CHRS |
| - |
| https://www.coherus.com/ |
|
Coherus Biosciences Inc. is a biotechnology compan..
>Volltext.. |
| 159.57 Mio. EUR |
| 42.4 Mio. EUR |
| 71.18 Mio. EUR |
| -140.26 Mio. EUR |
| -156.47 Mio. EUR |
| -1.35 EUR |
| 46.27 Mio. EUR |
| 88.03 Mio. EUR |
| -76.82 Mio. EUR |
| 0.51 |
| -73.95% |
| -38635.77% |
| - |
| - |
| - |
| - |
| COHERUS |
| 23.01.26 |
|
||||
|